Impact of Sex Hormones on Glioblastoma
Author Information
Author(s): Jessica Rossi, Marialuisa Zedde, Manuela Napoli, Rosario Pascarella, Anna Pisanello, Giuseppe Biagini, Franco Valzania
Primary Institution: University of Modena and Reggio Emilia
Hypothesis
The study investigates the role of sex hormones in the development and progression of glioblastoma, particularly focusing on sex-related differences.
Conclusion
Sex hormones significantly influence glioblastoma characteristics, with men showing worse survival outcomes compared to women.
Supporting Evidence
- Glioblastoma is 1.6 times more common in men than in women.
- Median survival time for males is 15.0 months compared to 25.5 months for females.
- Testosterone may promote tumor proliferation through the androgen receptor.
- Estrogen and progesterone have complex effects on glioblastoma.
- Female patients show increased genomic instability and higher MGMT promoter methylation.
Takeaway
This study looks at how hormones like testosterone and estrogen affect brain tumors called glioblastomas, showing that men tend to have worse outcomes than women.
Methodology
The review synthesizes existing literature on the effects of sex hormones on glioblastoma, including epidemiological data and biological mechanisms.
Potential Biases
The review notes potential biases in studies due to heterogeneous tumor histology and small sample sizes.
Limitations
The review highlights the challenges in identifying reliable hormonal tumor markers and the inconclusive results from studies due to small sample sizes.
Participant Demographics
The study discusses gender disparities in glioblastoma incidence and survival, noting that men are 1.6 times more likely to be diagnosed than women.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website